{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T16:10:05Z","timestamp":1792080605292,"version":"4.4.0"},"reference-count":179,"publisher":"Hindawi Limited","issue":"9","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":1217,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Depress Anxiety"],"published-print":{"date-parts":[[2012,9]]},"DOI":"10.1002\/da.21919","type":"journal-article","created":{"date-parts":[[2012,5,2]],"date-time":"2012-05-02T13:32:59Z","timestamp":1335965579000},"page":"762-774","source":"Crossref","is-referenced-by-count":82,"title":["NEURONAL NETWORK OF PANIC DISORDER: THE ROLE OF THE NEUROPEPTIDE CHOLECYSTOKININ"],"prefix":"10.1155","volume":"29","author":[{"given":"P.","family":"Zwanzger","sequence":"first","affiliation":[{"name":"Mood and Anxiety Disorders Research Unit; Department of Psychiatry and Psychotherapy; University of Muenster; Muenster; Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Domschke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Bradwejn","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, Faculty of Medicine; University of Ottawa; Ottawa; Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"98","published-online":{"date-parts":[[2012,5,2]]},"reference":[{"key":"10.1002\/da.21919-BIB21919-bib-0001|da21919-cit-0001","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1001\/archpsyc.1994.03950010008002","article-title":"Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Results from the National Comorbidity Survey","volume":"51","author":"Kessler","year":"1994","journal-title":"Arch Gen Psychiat"},{"key":"10.1002\/da.21919-BIB21919-bib-0002|da21919-cit-0002","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1001\/archpsyc.1997.01830160021003","article-title":"The cross-national epidemiology of panic disorder","volume":"54","author":"Weissman","year":"1997","journal-title":"Arch Gen Psychiat"},{"key":"10.1002\/da.21919-BIB21919-bib-0003|da21919-cit-0003","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1192\/bjp.176.3.229","article-title":"Lifetime panic-depression comorbidity in the National Comorbidity Survey. Association with symptoms, impairment, course and help-seeking","volume":"176","author":"Roy-Byrne","year":"2000","journal-title":"Brit J Psychiat"},{"key":"10.1002\/da.21919-BIB21919-bib-0004|da21919-cit-0004","volume-title":"Textbook of Anxiety Disorders","author":"Stein","year":"2003"},{"key":"10.1002\/da.21919-BIB21919-bib-0005|da21919-cit-0005","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1176\/appi.ajp.157.4.493","article-title":"Neuroanatomical hypothesis of panic disorder, revised","volume":"157","author":"Gorman","year":"2000","journal-title":"Am J Psychiat"},{"key":"10.1002\/da.21919-BIB21919-bib-0006|da21919-cit-0006","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1016\/S0006-3223(02)01665-7","article-title":"Startle reactivity and anxiety disorders: aversive conditioning, context, and neurobiology","volume":"52","author":"Grillon","year":"2002","journal-title":"Biol Psychiat"},{"key":"10.1002\/da.21919-BIB21919-bib-0007|da21919-cit-0007","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1002\/ajmg.c.30172","article-title":"Recent advances in the neurobiology of anxiety disorders: implications for novel therapeutics","volume":"148","author":"Mathew","year":"2008","journal-title":"Am J Med Genet C Semin Med Genet"},{"key":"10.1002\/da.21919-BIB21919-bib-0008|da21919-cit-0008","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1016\/j.cll.2010.07.006","article-title":"The neurobiology of anxiety disorders: brain imaging, genetics, and psychoneuroendocrinology","volume":"30","author":"Martin","year":"2010","journal-title":"Clin Lab Med"},{"key":"10.1002\/da.21919-BIB21919-bib-0009|da21919-cit-0009","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1038\/257604a0","article-title":"New peptide in the vertebrate CNS reacting with antigastrin antibodies","volume":"257","author":"Vanderhaeghen","year":"1975","journal-title":"Nature"},{"key":"10.1002\/da.21919-BIB21919-bib-0010|da21919-cit-0010","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1471-4159.1985.tb07105.x","article-title":"Neuronal cholecystokinin: one or multiple transmitters?","volume":"44","author":"Rehfeld","year":"1985","journal-title":"J Neurochem"},{"key":"10.1002\/da.21919-BIB21919-bib-0011|da21919-cit-0011","first-page":"41","volume-title":"Peptide Hormones Effects and Mechanisms of Action","author":"Beinfeld","year":"1988"},{"key":"10.1002\/da.21919-BIB21919-bib-0012|da21919-cit-0012","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/978-3-662-21705-4_2","volume-title":"Cholecystokinin and Anxiety: From Neuron to Behaviour","author":"Rehfeld","year":"1995"},{"key":"10.1002\/da.21919-BIB21919-bib-0013|da21919-cit-0013","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/0006-8993(86)91413-7","article-title":"Two brain cholecystokinin receptors: implications for behavioral actions","volume":"362","author":"Moran","year":"1986","journal-title":"Brain Res"},{"key":"10.1002\/da.21919-BIB21919-bib-0014|da21919-cit-0014","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/0165-6147(87)90062-9","article-title":"Classification and function of CCKreceptors","volume":"8","author":"Dourish","year":"1987","journal-title":"Trends Pharmacol Sci"},{"key":"10.1002\/da.21919-BIB21919-bib-0015|da21919-cit-0015","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1177\/070674379003500115","article-title":"Cholecystokinin-tetrapeptide induces panic attacks in patients with panic disorder","volume":"35","author":"Bradwejn","year":"1990","journal-title":"Can J Psychiat"},{"key":"10.1002\/da.21919-BIB21919-bib-0016|da21919-cit-0016","first-page":"91","article-title":"Dose ranging study of the effects of cholecystokinin in healthy volunteers","volume":"16","author":"Bradwejn","year":"1991","journal-title":"J Psychiat Neurosci"},{"key":"10.1002\/da.21919-BIB21919-bib-0017|da21919-cit-0017","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1001\/archpsyc.1991.01810310021005","article-title":"Enhanced sensitivity to cholecystokinin tetrapeptide in panic disorder. Clinical and behavioral findings","volume":"48","author":"Bradwejn","year":"1991","journal-title":"Arch Gen Psychiat"},{"key":"10.1002\/da.21919-BIB21919-bib-0018|da21919-cit-0018","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/S0165-0327(03)00110-1","article-title":"Sensitivity to cholecystokinin-tetrapeptide in major depression","volume":"80","author":"Koszycki","year":"2004","journal-title":"J Affect Disord"},{"key":"10.1002\/da.21919-BIB21919-bib-0019|da21919-cit-0019","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1002\/da.20012","article-title":"Effects of CCK-tetrapeptide in patients with social phobia and obsessive-compulsive disorder","volume":"20","author":"Katzman","year":"2004","journal-title":"Depress Anxiety"},{"key":"10.1002\/da.21919-BIB21919-bib-0020|da21919-cit-0020","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1111\/j.1749-6632.1994.tb44075.x","article-title":"The cholecystokinin hypothesis of anxiety and panic disorder","volume":"713","author":"Bradwejn","year":"1994","journal-title":"Ann NY Acad Sci"},{"key":"10.1002\/da.21919-BIB21919-bib-0021|da21919-cit-0021","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1176\/ajp.149.7.962","article-title":"Replication of action of cholecystokinin tetrapeptide in panic disorder: clinical and behavioral findings","volume":"149","author":"Bradwejn","year":"1992","journal-title":"Am J Psychiat"},{"key":"10.1002\/da.21919-BIB21919-bib-0022|da21919-cit-0022","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1007\/s002130050201","article-title":"Effect of the selective serotonin reuptake inhibitor fluvoxamine on CCK-4 induced panic attacks","volume":"129","author":"van Megen","year":"1997","journal-title":"Psychopharmacology"},{"key":"10.1002\/da.21919-BIB21919-bib-0023|da21919-cit-0023","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1002\/da.10099","article-title":"Effects of tiagabine on cholecystokinin-tetrapeptide (CCK-4)-induced anxiety in healthy volunteers","volume":"18","author":"Zwanzger","year":"2003","journal-title":"Depress Anxiety"},{"key":"10.1002\/da.21919-BIB21919-bib-0024|da21919-cit-0024","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1001\/archpsyc.1989.01810060031006","article-title":"Cholecystokinin tetrapeptide induces panic-like attacks in healthy volunteers. Preliminary findings","volume":"46","author":"Montigny","year":"1989","journal-title":"Arch Gen Psychiat"},{"key":"10.1002\/da.21919-BIB21919-bib-0025|da21919-cit-0025","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1176\/ajp.151.2.261","article-title":"Imipramine antagonism of the panicogenic effects of cholecystokinin tetrapeptide in panic disorder patients","volume":"151","author":"Bradwejn","year":"1994","journal-title":"Am J Psychiat"},{"key":"10.1002\/da.21919-BIB21919-bib-0026|da21919-cit-0026","first-page":"332","article-title":"Effects of citalopram treatment on behavioural, cardiovascular and neuroendocrine response to cholecystokinin tetrapeptide challenge in patients with panic disorder","volume":"22","author":"Shlik","year":"1997","journal-title":"J Psychiat Neurosci"},{"key":"10.1002\/da.21919-BIB21919-bib-0027|da21919-cit-0027","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1176\/ajp.155.2.283","article-title":"Effect of aging on cholecystokinin-induced panic","volume":"155","author":"Flint","year":"1998","journal-title":"Am J Psychiat"},{"key":"10.1002\/da.21919-BIB21919-bib-0028|da21919-cit-0028","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1007\/s00213-007-0738-7","article-title":"Evaluation of the CCK-4 model as a challenge paradigm in a population of healthy volunteers within a proof-of-concept study","volume":"192","author":"Eser","year":"2007","journal-title":"Psychopharmacology"},{"key":"10.1002\/da.21919-BIB21919-bib-0029|da21919-cit-0029","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/S0893-133X(01)00266-4","article-title":"Vigabatrin decreases cholecystokinin-tetrapeptide (CCK-4) induced panic in healthy volunteers","volume":"25","author":"Zwanzger","year":"2001","journal-title":"Neuropsychopharmacology"},{"key":"10.1002\/da.21919-BIB21919-bib-0030|da21919-cit-0030","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1055\/s-0029-1241798","article-title":"Effects of the GABA-reuptake inhibitor tiagabine on panic and anxiety in patients with panic disorder","volume":"42","author":"Zwanzger","year":"2009","journal-title":"Pharmacopsychiatry"},{"key":"10.1002\/da.21919-BIB21919-bib-0031|da21919-cit-0031","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1055\/s-2005-837768","article-title":"Randomized, double-blind study of SR142801 (Osanetant). A novel neurokinin-3 (NK3) receptor antagonist in panic disorder with pre- and posttreatment cholecystokinin tetrapeptide (CCK-4) challenges","volume":"38","author":"Kronenberg","year":"2005","journal-title":"Pharmacopsychiatry"},{"key":"10.1002\/da.21919-BIB21919-bib-0032|da21919-cit-0032","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1126\/science.1175055","article-title":"Translocator protein (18 kD) as target for anxiolytics without benzodiazepine-like side effects","volume":"325","author":"Rupprecht","year":"2009","journal-title":"Science"},{"key":"10.1002\/da.21919-BIB21919-bib-0033|da21919-cit-0033","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1007\/s00213-004-2025-1","article-title":"Effects of a metabotropic glutamate(2\/3) receptor agonist (LY544344\/LY354740) on panic anxiety induced by cholecystokinin tetrapeptide in healthy humans: preliminary results","volume":"179","author":"Kellner","year":"2005","journal-title":"Psychopharmacology"},{"key":"10.1002\/da.21919-BIB21919-bib-0034|da21919-cit-0034","doi-asserted-by":"crossref","first-page":"2376","DOI":"10.1176\/appi.ajp.162.12.2376","article-title":"The acute antipanic activity of aerobic exercise","volume":"162","author":"Strohle","year":"2005","journal-title":"Am J Psychiat"},{"key":"10.1002\/da.21919-BIB21919-bib-0035|da21919-cit-0035","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1016\/j.jpsychires.2009.02.004","article-title":"The acute antipanic and anxiolytic activity of aerobic exercise in patients with panic disorder and healthy control subjects","volume":"43","author":"Strohle","year":"2009","journal-title":"J Psychiat Res"},{"key":"10.1002\/da.21919-BIB21919-bib-0036|da21919-cit-0036","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1016\/j.jpsychires.2008.09.001","article-title":"The selective serotonin re-uptake inhibitor escitalopram modulates the panic response to cholecystokinin tetrapeptide in healthy men depending on 5-HTTLPRgenotype","volume":"43","author":"Kellner","year":"2009","journal-title":"J Psychiat Res"},{"key":"10.1002\/da.21919-BIB21919-bib-0037|da21919-cit-0037","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1016\/0006-3223(94)00190-E","article-title":"A placebo-controlled trial of L-365,260, a CCKBantagonist, in panic disorder","volume":"37","author":"Kramer","year":"1995","journal-title":"Biol Psychiat"},{"key":"10.1002\/da.21919-BIB21919-bib-0038|da21919-cit-0038","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1016\/S0006-3223(99)00090-6","article-title":"Placebo-controlled trial of the CCK-Bantagonist, CI-988, in panic disorder","volume":"46","author":"Pande","year":"1999","journal-title":"Biol Psychiat"},{"key":"10.1002\/da.21919-BIB21919-bib-0039|da21919-cit-0039","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/0196-9781(83)90143-2","article-title":"Extra-hippocampal projections of CCK neurons of the hippocampus and subiculum","volume":"4","author":"Handelmann","year":"1983","journal-title":"Peptides"},{"key":"10.1002\/da.21919-BIB21919-bib-0040|da21919-cit-0040","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1002\/cne.902930405","article-title":"Cholecystokinin-, galanin-, and corticotropin-releasing factor-like immunoreactive projections from the nucleus of the solitary tract to the parabrachial nucleus in the rat","volume":"293","author":"Herbert","year":"1990","journal-title":"J Comp Neurol"},{"key":"10.1002\/da.21919-BIB21919-bib-0041|da21919-cit-0041","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/0006-8993(84)91208-3","article-title":"Brainstem projection to the hypothalamic ventromedial nucleus in the rat: a CCK-containing long ascending pathway","volume":"303","author":"Zaborszky","year":"1984","journal-title":"Brain Res"},{"key":"10.1002\/da.21919-BIB21919-bib-0042|da21919-cit-0042","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/0006-8993(84)90806-0","article-title":"Cholecystokinin in the hypothalamo-hypophyseal system","volume":"299","author":"Palkovits","year":"1984","journal-title":"Brain Res"},{"key":"10.1002\/da.21919-BIB21919-bib-0043|da21919-cit-0043","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/0304-3940(82)90204-X","article-title":"Coexistence of substance P- and cholecystokinin-like immunoreactivity in neurons of the mesencephalic periaqueductal central gray","volume":"28","author":"Skirboll","year":"1982","journal-title":"Neurosci Lett"},{"key":"10.1002\/da.21919-BIB21919-bib-0044|da21919-cit-0044","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/0169-328X(88)90024-1","article-title":"The distribution of thalamic projection neurons containing cholecystokinin messenger RNA, using in situ hybridization histochemistry and retrograde labeling","volume":"464","author":"Burgunder","year":"1988","journal-title":"Brain Res"},{"key":"10.1002\/da.21919-BIB21919-bib-0045|da21919-cit-0045","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/0169-328X(94)00282-J","article-title":"Expression of cholecystokinin mRNA in corticothalamic projecting neurons: a combined fluorescence in situ hybridization and retrograde tracing study in the ventrolateral thalamus of the rat","volume":"30","author":"Senatorov","year":"1995","journal-title":"Brain Res Mol Brain Res"},{"key":"10.1002\/da.21919-BIB21919-bib-0046|da21919-cit-0046","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1126\/science.7053570","article-title":"Origin of the cholecystokinin-containing fibers in the rat caudatoputamen","volume":"215","author":"Meyer","year":"1982","journal-title":"Science"},{"key":"10.1002\/da.21919-BIB21919-bib-0047|da21919-cit-0047","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1016\/0306-4522(94)90297-6","article-title":"Cholecystokinin corticostriatal pathway in the rat: evidence for bilateral origin from medial prefrontal cortical areas","volume":"59","author":"Morino","year":"1994","journal-title":"Neuroscience"},{"key":"10.1002\/da.21919-BIB21919-bib-0048|da21919-cit-0048","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1016\/S0006-3223(98)00348-5","article-title":"Neuroanatomic correlates of CCK-4-induced panic attacks in healthy humans: a comparison of two time points","volume":"45","author":"Javanmard","year":"1999","journal-title":"Biol Psychiat"},{"key":"10.1002\/da.21919-BIB21919-bib-0049|da21919-cit-0049","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/S0006-3223(96)00334-4","article-title":"The effect of cholecystokinin tetrapeptide on respiratory resistance in healthy volunteers","volume":"42","author":"Shlik","year":"1997","journal-title":"Biol Psychiat"},{"key":"10.1002\/da.21919-BIB21919-bib-0050|da21919-cit-0050","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1016\/j.neuroimage.2006.01.035","article-title":"Functional magnetic resonance imaging characterization of CCK-4-induced panic attack and subsequent anticipatory anxiety","volume":"31","author":"Schunck","year":"2006","journal-title":"Neuroimage"},{"key":"10.1002\/da.21919-BIB21919-bib-0051|da21919-cit-0051","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1002\/hbm.20522","article-title":"Functional neuroanatomy of CCK-4-induced panic attacks in healthy volunteers","volume":"30","author":"Eser","year":"2009","journal-title":"Hum Brain Mapp"},{"key":"10.1002\/da.21919-BIB21919-bib-0052|da21919-cit-0052","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/(SICI)1520-6394(1998)8:1<1::AID-DA1>3.0.CO;2-G","article-title":"Behavioral, cardiovascular, and neuroendocrine profiles following CCK-4 challenge in healthy volunteers: a comparison of panickers and nonpanickers","volume":"8","author":"Koszycki","year":"1998","journal-title":"Depress Anxiety"},{"key":"10.1002\/da.21919-BIB21919-bib-0053|da21919-cit-0053","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/s002130050371","article-title":"Influence of clonidine on psychopathological, endocrine and respiratory effects of cholecystokinin tetrapeptide in patients with panic disorder","volume":"133","author":"Kellner","year":"1997","journal-title":"Psychopharmacology"},{"key":"10.1002\/da.21919-BIB21919-bib-0054|da21919-cit-0054","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/S0893-133X(99)00115-3","article-title":"Increased ACTHconcentrations associated with cholecystokinin tetrapeptide-induced panic attacks in patients with panic disorder","volume":"22","author":"Strohle","year":"2000","journal-title":"Neuropsychopharmacology"},{"key":"10.1002\/da.21919-BIB21919-bib-0055|da21919-cit-0055","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1016\/j.psyneuen.2004.01.009","article-title":"Effects of propranolol on symptom and endocrine responses to pentagastrin","volume":"29","author":"Khan","year":"2004","journal-title":"Psychoneuroendocrinology"},{"key":"10.1002\/da.21919-BIB21919-bib-0056|da21919-cit-0056","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1002\/hup.417","article-title":"Acute cholecystokinin effects on event-related potentials in healthy volunteers","volume":"17","author":"Knott","year":"2002","journal-title":"Hum Psychopharmacol"},{"key":"10.1002\/da.21919-BIB21919-bib-0057|da21919-cit-0057","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/S0278-5846(02)00350-0","article-title":"Effects of acute cholecystokinin infusion on hemispheric EEGasymmetry and coherence in healthy volunteers","volume":"27","author":"Knott","year":"2003","journal-title":"Prog Neuropsychopharmacol Biol Psychiat"},{"key":"10.1002\/da.21919-BIB21919-bib-0058|da21919-cit-0058","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1017\/S146114570600695X","article-title":"Effects of repetitive transcranial magnetic stimulation (rTMS) on panic attacks induced by cholecystokinin-tetrapeptide (CCK-4)","volume":"10","author":"Zwanzger","year":"2007","journal-title":"Int J Neuropsychopharmacol"},{"issue":"Suppl 2","key":"10.1002\/da.21919-BIB21919-bib-0059|da21919-cit-0059","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/0196-9781(81)90015-2","article-title":"Cholecystokinin in the central nervous system","author":"Beinfeld","year":"1981","journal-title":"Peptides"},{"key":"10.1002\/da.21919-BIB21919-bib-0060|da21919-cit-0060","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1097\/00001756-199312000-00009","article-title":"Brain cholecystokinin tetrapeptide levels are increased in a rat model of anxiety","volume":"5","author":"Pavlasevic","year":"1993","journal-title":"Neuroreport"},{"key":"10.1002\/da.21919-BIB21919-bib-0061|da21919-cit-0061","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1111\/j.1460-9568.1992.tb00906.x","article-title":"Autoradiographic localization of cholecystokinin A and B receptors in rat brain using [125I]d-Tyr25 (Nle28,31)-CCK25 - 33S","volume":"4","author":"Carlberg","year":"1992","journal-title":"Eur J Neurosci"},{"key":"10.1002\/da.21919-BIB21919-bib-0062|da21919-cit-0062","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1006\/mcne.1993.1018","article-title":"Differential gene expression of CCK(A) and CCK(B) receptors in the rat brain","volume":"4","author":"Honda","year":"1993","journal-title":"Mol Cell Neurosci"},{"key":"10.1002\/da.21919-BIB21919-bib-0063|da21919-cit-0063","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/S0006-8993(96)00477-5","article-title":"On the distribution of cholecystokinin Breceptors in monkey brain","volume":"738","author":"Mercer","year":"1996","journal-title":"Brain Res"},{"key":"10.1002\/da.21919-BIB21919-bib-0064|da21919-cit-0064","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1523\/JNEUROSCI.03-04-00877.1983","article-title":"Autoradiographic localization of cholecystokinin receptors in rodent brain","volume":"3","author":"Zarbin","year":"1983","journal-title":"J Neurosci"},{"key":"10.1002\/da.21919-BIB21919-bib-0065|da21919-cit-0065","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1146\/annurev.ne.15.030192.002033","article-title":"The role of the amygdala in fear and anxiety","volume":"15","author":"Davis","year":"1992","journal-title":"Annu Rev Neurosci"},{"key":"10.1002\/da.21919-BIB21919-bib-0066|da21919-cit-0066","doi-asserted-by":"crossref","first-page":"2517","DOI":"10.1523\/JNEUROSCI.08-07-02517.1988","article-title":"Different projections of the central amygdaloid nucleus mediate autonomic and behavioral correlates of conditioned fear","volume":"8","author":"LeDoux","year":"1988","journal-title":"J Neurosci"},{"key":"10.1002\/da.21919-BIB21919-bib-0067|da21919-cit-0067","volume-title":"The neuropsychology of anxiety","author":"Gray","year":"1982"},{"key":"10.1002\/da.21919-BIB21919-bib-0068|da21919-cit-0068","doi-asserted-by":"crossref","first-page":"R803","DOI":"10.1152\/ajpregu.00682.2007","article-title":"Characterization of mice lacking the gene for cholecystokinin","volume":"294","author":"Lo","year":"2008","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"10.1002\/da.21919-BIB21919-bib-0069|da21919-cit-0069","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1002\/da.20032","article-title":"Different pathways mediated by CCK1 and CCK2 receptors: effect of intraperitonal mrna antisense oligodeoxynucleotides to cholecystokinin on anxiety-like and learning behaviors in rats","volume":"20","author":"Cohen","year":"2004","journal-title":"Depress Anxiety"},{"key":"10.1002\/da.21919-BIB21919-bib-0070|da21919-cit-0070","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1016\/S0006-3223(98)00010-9","article-title":"Inhibition of anxiety in rats by antisense to cholecystokinin precursor protein","volume":"44","author":"Cohen","year":"1998","journal-title":"Biol Psychiat"},{"key":"10.1002\/da.21919-BIB21919-bib-0071|da21919-cit-0071","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1016\/S0361-9230(00)00407-X","article-title":"Increased anxiety behavior in OLETFrats without cholecystokinin-A receptor","volume":"53","author":"Yamamoto","year":"2000","journal-title":"Brain Res Bull"},{"key":"10.1002\/da.21919-BIB21919-bib-0072|da21919-cit-0072","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1038\/sj.bjp.0701186","article-title":"Pharmacological evaluation of IQM-95,333, a highly selective CCKAreceptor antagonist with anxiolytic-like activity in animal models","volume":"121","author":"Ballaz","year":"1997","journal-title":"Brit J Pharmacol"},{"key":"10.1002\/da.21919-BIB21919-bib-0073|da21919-cit-0073","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/0031-9384(93)90077-S","article-title":"The effects of CCKAand CCKBantagonists on activity in the black\/white exploration model of anxiety in mice","volume":"54","author":"Hendrie","year":"1993","journal-title":"Physiol Behav"},{"key":"10.1002\/da.21919-BIB21919-bib-0074|da21919-cit-0074","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/S0304-3940(02)01176-X","article-title":"Anxiety-related behaviors in cholecystokinin-A, B, and ABreceptor gene knockout mice in the plus-maze","volume":"335","author":"Miyasaka","year":"2002","journal-title":"Neurosci Lett"},{"key":"10.1002\/da.21919-BIB21919-bib-0075|da21919-cit-0075","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1016\/0028-3908(94)90112-0","article-title":"Evidence for potentiation by CCKantagonists of the effect of cholecystokinin octapeptide in the elevated plus-maze","volume":"33","author":"Vasar","year":"1994","journal-title":"Neuropharmacology"},{"key":"10.1002\/da.21919-BIB21919-bib-0076|da21919-cit-0076","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1007\/BF02247441","article-title":"Ethological analysis of cholecystokinin (CCKAand CCKB) receptor ligands in the elevated plus-maze test of anxiety in mice","volume":"124","author":"Johnson","year":"1996","journal-title":"Psychopharmacology"},{"key":"10.1002\/da.21919-BIB21919-bib-0077|da21919-cit-0077","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/0006-8993(91)91139-R","article-title":"\u2018Anxiolytic\u2019 effect of CCK-antagonists on plus-maze behavior in mice","volume":"548","author":"Rataud","year":"1991","journal-title":"Brain Res"},{"key":"10.1002\/da.21919-BIB21919-bib-0078|da21919-cit-0078","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/S0028-3908(97)00011-7","article-title":"The effects of cholecystokinin Aand Breceptor antagonists on exploratory behaviour in the elevated zero-maze in rat","volume":"36","author":"Matto","year":"1997","journal-title":"Neuropharmacology"},{"key":"10.1002\/da.21919-BIB21919-bib-0079|da21919-cit-0079","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.bbr.2010.03.038","article-title":"Anxiety-like behavior and locomotion in CCK1 knockout rats as a function of strain, sex and early maternal environment","volume":"211","author":"Schroeder","year":"2010","journal-title":"Behav Brain Res"},{"key":"10.1002\/da.21919-BIB21919-bib-0080|da21919-cit-0080","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1007\/s00213-005-2255-x","article-title":"Targeted invalidation of CCK2 receptor gene induces anxiolytic-like action in light-dark exploration, but not in fear conditioning test","volume":"181","author":"Raud","year":"2005","journal-title":"Psychopharmacology"},{"key":"10.1002\/da.21919-BIB21919-bib-0081|da21919-cit-0081","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S0924-977X(03)00103-2","article-title":"Reduced anxious behavior in mice lacking the CCK2 receptor gene","volume":"14","author":"Horinouchi","year":"2004","journal-title":"Eur Neuropsychopharmacol"},{"key":"10.1002\/da.21919-BIB21919-bib-0082|da21919-cit-0082","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1007\/s00213-003-1453-7","article-title":"Targeted mutation of CCK2 receptor gene modifies the behavioural effects of diazepam in female mice","volume":"168","author":"Raud","year":"2003","journal-title":"Psychopharmacology"},{"key":"10.1002\/da.21919-BIB21919-bib-0083|da21919-cit-0083","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/S0924-977X(96)00033-8","article-title":"Behavioral effects of CCKBreceptor ligands in a validated simulation of panic anxiety in rats","volume":"6","author":"Jenck","year":"1996","journal-title":"Eur Neuropsychopharmacol"},{"key":"10.1002\/da.21919-BIB21919-bib-0084|da21919-cit-0084","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1023\/A:1024907207370","article-title":"Pharmacogenetic study of anxiolytic effects of new cholecystokinin receptor antagonists in animals with different levels of emotionality","volume":"135","author":"Kolik","year":"2003","journal-title":"Bull Exp Biol Med"},{"key":"10.1002\/da.21919-BIB21919-bib-0085|da21919-cit-0085","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1054\/npep.1999.0766","article-title":"Suppression of conditioned fear by administration of CCKBreceptor antagonist PD135158","volume":"33","author":"Tsutsumi","year":"1999","journal-title":"Neuropeptides"},{"key":"10.1002\/da.21919-BIB21919-bib-0086|da21919-cit-0086","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1021\/jm00057a005","article-title":"Cholecystokinin dipeptoid antagonists: design, synthesis, and anxiolytic profile of some novel CCK-A and CCK-B selective and \u201cmixed\u201d CCK-A\/CCK-Bantagonists","volume":"36","author":"Boden","year":"1993","journal-title":"J Med Chem"},{"key":"10.1002\/da.21919-BIB21919-bib-0087|da21919-cit-0087","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1111\/j.1476-5381.1992.tb14201.x","article-title":"The antagonism of benzodiazepine withdrawal effects by the selective cholecystokininB receptor antagonist CI-988","volume":"105","author":"Singh","year":"1992","journal-title":"Brit J Pharmacol"},{"key":"10.1002\/da.21919-BIB21919-bib-0088|da21919-cit-0088","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1111\/j.1476-5381.1991.tb12413.x","article-title":"The behavioural properties of CI-988, a selective cholecystokininB receptor antagonist","volume":"104","author":"Singh","year":"1991","journal-title":"Brit J Pharmacol"},{"issue":"19 Suppl","key":"10.1002\/da.21919-BIB21919-bib-0089|da21919-cit-0089","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/0143-4179(91)90084-V","article-title":"Anxiolytic effects of CCK-Bantagonists","author":"Costall","year":"1991","journal-title":"Neuropeptides"},{"key":"10.1002\/da.21919-BIB21919-bib-0090|da21919-cit-0090","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1021\/jm00105a062","article-title":"Rationally designed \u201cdipeptoid\u201d analogues of CCK. alpha-Methyltryptophan derivatives as highly selective and orally active gastrin and CCK-Bantagonists with potent anxiolytic properties","volume":"34","author":"Horwell","year":"1991","journal-title":"J Med Chem"},{"key":"10.1002\/da.21919-BIB21919-bib-0091|da21919-cit-0091","doi-asserted-by":"crossref","first-page":"6728","DOI":"10.1073\/pnas.87.17.6728","article-title":"Development of a class of selective cholecystokinin type Breceptor antagonists having potent anxiolytic activity","volume":"87","author":"Hughes","year":"1990","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1002\/da.21919-BIB21919-bib-0092|da21919-cit-0092","doi-asserted-by":"crossref","first-page":"3881","DOI":"10.1073\/pnas.0505407103","article-title":"Elevated cholecystokininergic tone constitutes an important molecular\/neuronal mechanism for the expression of anxiety in the mouse","volume":"103","author":"Chen","year":"2006","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1002\/da.21919-BIB21919-bib-0093|da21919-cit-0093","doi-asserted-by":"crossref","first-page":"e15999","DOI":"10.1371\/journal.pone.0015999","article-title":"Bi-directional effect of cholecystokinin receptor-2 overexpression on stress-triggered fear memory and anxiety in the mouse","volume":"5","author":"Chen","year":"2010","journal-title":"PLoS One"},{"key":"10.1002\/da.21919-BIB21919-bib-0094|da21919-cit-0094","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.brainres.2005.08.006","article-title":"Involvement of dorsolateral periaqueductal gray cholecystokinin-2 receptors in the regulation of a panic-related behavior in rats","volume":"1059","author":"Bertoglio","year":"2005","journal-title":"Brain Res"},{"key":"10.1002\/da.21919-BIB21919-bib-0095|da21919-cit-0095","doi-asserted-by":"crossref","first-page":"1935","DOI":"10.1016\/j.peptides.2004.06.016","article-title":"Systemic and intra-dorsal periaqueductal gray injections of cholecystokinin sulfated octapeptide (CCK-8s) induce a panic-like response in rats submitted to the elevated T-maze","volume":"25","author":"Zanoveli","year":"2004","journal-title":"Peptides"},{"key":"10.1002\/da.21919-BIB21919-bib-0096|da21919-cit-0096","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/sj.npp.1300334","article-title":"Anxiogenic effect of cholecystokinin in the dorsal periaqueductal gray","volume":"29","author":"Netto","year":"2004","journal-title":"Neuropsychopharmacology"},{"key":"10.1002\/da.21919-BIB21919-bib-0097|da21919-cit-0097","doi-asserted-by":"crossref","first-page":"1838","DOI":"10.1523\/JNEUROSCI.17-05-01838.1997","article-title":"Activation of amygdala cholecystokinin B receptors potentiates the acoustic startle response in the rat","volume":"17","author":"Frankland","year":"1997","journal-title":"J Neurosci"},{"key":"10.1002\/da.21919-BIB21919-bib-0098|da21919-cit-0098","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1007\/s00726-001-0139-x","article-title":"Role of cholecystokinin-A and cholecystokinin-B receptors in anxiety","volume":"23","author":"Hernandez-Gomez","year":"2002","journal-title":"Amino Acids"},{"key":"10.1002\/da.21919-BIB21919-bib-0099|da21919-cit-0099","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/0014-2999(95)00859-4","article-title":"Effect of the selective CCKBreceptor antagonist LY288513 on conditioned fear stress in rats","volume":"300","author":"Izumi","year":"1996","journal-title":"Eur J Pharmacol"},{"key":"10.1002\/da.21919-BIB21919-bib-0100|da21919-cit-0100","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1055\/s-2001-18030","article-title":"Suppression of conditioned fear by administration of CCKBreceptor antisense oligodeoxynucleotide into the lateral ventricle","volume":"34","author":"Tsutsumi","year":"2001","journal-title":"Pharmacopsychiatry"},{"key":"10.1002\/da.21919-BIB21919-bib-0101|da21919-cit-0101","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/j.pbb.2011.01.022","article-title":"Blockade of CRF1 and CCK2 receptors attenuated the elevated anxiety-like behavior induced by immobilization stress","volume":"98","author":"Wang","year":"2011","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1002\/da.21919-BIB21919-bib-0102|da21919-cit-0102","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1097\/00008877-199711000-00013","article-title":"CCKreceptor antagonists in animal models of anxiety: comparison between exploration tests, conflict procedures and a model based on defensive behaviours","volume":"8","author":"Griebel","year":"1997","journal-title":"Behav Pharmacol"},{"key":"10.1002\/da.21919-BIB21919-bib-0103|da21919-cit-0103","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1007\/s00213-002-1181-4","article-title":"Decreased CCK(B) receptor binding in rat amygdala in animals demonstrating greater anxiety-like behavior","volume":"164","author":"Wunderlich","year":"2002","journal-title":"Psychopharmacology"},{"key":"10.1002\/da.21919-BIB21919-bib-0104|da21919-cit-0104","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1016\/S0893-133X(01)00291-3","article-title":"Behavioral profile of CCK2 receptor-deficient mice","volume":"25","author":"Dauge","year":"2001","journal-title":"Neuropsychopharmacology"},{"key":"10.1002\/da.21919-BIB21919-bib-0105|da21919-cit-0105","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.neulet.2008.07.075","article-title":"Behavioural differences between C57BL\/6 and 129S6\/SvEv strains are reinforced by environmental enrichment","volume":"443","author":"Abramov","year":"2008","journal-title":"Neurosci Lett"},{"key":"10.1002\/da.21919-BIB21919-bib-0106|da21919-cit-0106","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.bbr.2008.04.027","article-title":"Different housing conditions alter the behavioural phenotype of CCK(2) receptor-deficient mice","volume":"193","author":"Abramov","year":"2008","journal-title":"Behav Brain Res"},{"key":"10.1002\/da.21919-BIB21919-bib-0107|da21919-cit-0107","first-page":"33","article-title":"Cholecystokinin-induced anxiety in rats: relevance of pre-experimental stress and seasonal variations","volume":"25","author":"Koks","year":"2000","journal-title":"J Psychiatry Neurosci"},{"key":"10.1002\/da.21919-BIB21919-bib-0108|da21919-cit-0108","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/0091-3057(94)90445-6","article-title":"PD135158, a CCK-Bantagonist, reduces \u201cstate,\u201d but not \u201ctrait\u201d anxiety in mice","volume":"49","author":"Belzung","year":"1994","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1002\/da.21919-BIB21919-bib-0109|da21919-cit-0109","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/0091-3057(94)90467-7","article-title":"Heterogeneity of CCK-Breceptors involved in animal models of anxiety","volume":"49","author":"Derrien","year":"1994","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1002\/da.21919-BIB21919-bib-0110|da21919-cit-0110","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1034\/j.1600-0447.108.s417.3.x","article-title":"Neuroanatomical circuits modulating fear and anxiety behaviors","volume":"417","author":"Charney","year":"2003","journal-title":"Acta Psychiatr Scand Suppl"},{"key":"10.1002\/da.21919-BIB21919-bib-0111|da21919-cit-0111","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1111\/j.1476-5381.1991.tb12225.x","article-title":"Pharmacology of a cholecystokinin receptor on 5-hydroxytryptamine neurones in the dorsal raphe of the rat brain","volume":"102","author":"Boden","year":"1991","journal-title":"Brit J Pharmacol"},{"key":"10.1002\/da.21919-BIB21919-bib-0112|da21919-cit-0112","first-page":"37","article-title":"Effect of cholecystokinin octapeptide sulphate ester on brain monoamines in the rat","volume":"57","author":"Fekete","year":"1981","journal-title":"Acta Physiol Acad Sci Hung"},{"key":"10.1002\/da.21919-BIB21919-bib-0113|da21919-cit-0113","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/0028-3908(88)90152-9","article-title":"Effect of cholecystokinin tetrapeptide amide on the metabolism of 5-hydroxytryptamine in the rat brain","volume":"27","author":"Itoh","year":"1988","journal-title":"Neuropharmacology"},{"key":"10.1002\/da.21919-BIB21919-bib-0114|da21919-cit-0114","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/0028-3908(94)90087-6","article-title":"Effects of BOC-CCK-4 and L365.260 on cortical 5-HT release in guinea-pigs on exposure to the elevated plus maze","volume":"33","author":"Rex","year":"1994","journal-title":"Neuropharmacology"},{"key":"10.1002\/da.21919-BIB21919-bib-0115|da21919-cit-0115","doi-asserted-by":"crossref","first-page":"1790","DOI":"10.1111\/j.1476-5381.1991.tb09864.x","article-title":"Cholecystokinin release mediated by 5-HT3 receptors in rat cerebral cortex and nucleus accumbens","volume":"103","author":"Paudice","year":"1991","journal-title":"Brit J Pharmacol"},{"key":"10.1002\/da.21919-BIB21919-bib-0116|da21919-cit-0116","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1007\/BF00168781","article-title":"Inhibition by 5-HT3 receptor antagonists of release of cholecystokinin-like immunoreactivity from the frontal cortex of freely moving rats","volume":"347","author":"Raiteri","year":"1993","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"10.1002\/da.21919-BIB21919-bib-0117|da21919-cit-0117","first-page":"279","article-title":"Anxiogenic effect of central CCKadministration is attenuated by chronic fluoxetine or ipsapirone treatment","volume":"38","author":"To","year":"1999","journal-title":"Neuropharmacology"},{"key":"10.1002\/da.21919-BIB21919-bib-0118|da21919-cit-0118","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/S0893-133X(98)00074-8","article-title":"Acute and chronic role of 5-HT3 neuronal system on behavioral and neuroendocrine changes induced by intravenous cholecystokinin tetrapeptide administration in humans","volume":"20","author":"Depot","year":"1999","journal-title":"Neuropsychopharmacology"},{"key":"10.1002\/da.21919-BIB21919-bib-0119|da21919-cit-0119","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1007\/BF02246976","article-title":"Ondansetron, an antagonist of 5-HT3 receptors, antagonizes the anti-exploratory effect of caerulein, an agonist of CCKreceptors, in the elevated plus-maze","volume":"110","author":"Vasar","year":"1993","journal-title":"Psychopharmacology"},{"key":"10.1002\/da.21919-BIB21919-bib-0120|da21919-cit-0120","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1080\/15622970410029927","article-title":"Association between serotonin-related genetic polymorphisms and CCK-4-induced panic attacks with or without 5-hydroxytryptophan pretreatment in healthy volunteers","volume":"5","author":"Maron","year":"2004","journal-title":"World J Biol Psychiat"},{"key":"10.1002\/da.21919-BIB21919-bib-0121|da21919-cit-0121","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1016\/0006-3223(95)00479-3","article-title":"Effect of acute tryptophan depletion on behavioral, cardiovascular, and hormonal sensitivity to cholecystokinin-tetrapeptide challenge in healthy volunteers","volume":"40","author":"Koszycki","year":"1996","journal-title":"Biol Psychiat"},{"key":"10.1002\/da.21919-BIB21919-bib-0122|da21919-cit-0122","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.neulet.2008.09.052","article-title":"Association testing of panic disorder candidate genes using CCK-4 challenge in healthy volunteers","volume":"446","author":"Maron","year":"2008","journal-title":"Neurosci Lett"},{"key":"10.1002\/da.21919-BIB21919-bib-0123|da21919-cit-0123","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1016\/S0006-3223(02)01672-4","article-title":"Molecular targets in the treatment of anxiety","volume":"52","author":"Kent","year":"2002","journal-title":"Biol Psychiat"},{"key":"10.1002\/da.21919-BIB21919-bib-0124|da21919-cit-0124","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/S0006-3223(99)00188-2","article-title":"SPECT[I-123]iomazenil measurement of the benzodiazepine receptor in panic disorder","volume":"47","author":"Bremner","year":"2000","journal-title":"Biol Psychiat"},{"key":"10.1002\/da.21919-BIB21919-bib-0125|da21919-cit-0125","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1001\/archpsyc.55.8.715","article-title":"Decreased brain GABA(A)-benzodiazepine receptor binding in panic disorder: preliminary results from a quantitative PETstudy","volume":"55","author":"Malizia","year":"1998","journal-title":"Arch Gen Psychiat"},{"key":"10.1002\/da.21919-BIB21919-bib-0126|da21919-cit-0126","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1001\/archpsyc.58.6.556","article-title":"Reductions in occipital cortex GABAlevels in panic disorder detected with 1h-magnetic resonance spectroscopy","volume":"58","author":"Goddard","year":"2001","journal-title":"Arch Gen Psychiat"},{"key":"10.1002\/da.21919-BIB21919-bib-0127|da21919-cit-0127","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1038\/312363a0","article-title":"Benzodiazepines antagonize cholecystokinin-induced activation of rat hippocampal neurones","volume":"312","author":"Bradwejn","year":"1984","journal-title":"Nature"},{"key":"10.1002\/da.21919-BIB21919-bib-0128|da21919-cit-0128","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1001\/archpsyc.60.2.161","article-title":"Induced panic attacks shift gamma-aminobutyric acid type A receptor modulatory neuroactive steroid composition in patients with panic disorder: preliminary results","volume":"60","author":"Strohle","year":"2003","journal-title":"Arch Gen Psychiat"},{"key":"10.1002\/da.21919-BIB21919-bib-0129|da21919-cit-0129","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1038\/sj.npp.1300572","article-title":"Panic induction with cholecystokinin-tetrapeptide (CCK-4) increases plasma concentrations of the neuroactive steroid 3alpha, 5alpha tetrahydrodeoxycorticosterone (3alpha, 5alpha-THDOC) in healthy volunteers","volume":"30","author":"Eser","year":"2005","journal-title":"Neuropsychopharmacology"},{"key":"10.1002\/da.21919-BIB21919-bib-0130|da21919-cit-0130","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1016\/j.psyneuen.2009.04.017","article-title":"Changes in CCK-4 induced panic after treatment with the GABA-reuptake inhibitor tiagabine are associated with an increase in 3alpha,5alpha-tetrahydrodeoxycorticosterone concentrations","volume":"34","author":"Zwanzger","year":"2009","journal-title":"Psychoneuroendocrinology"},{"key":"10.1002\/da.21919-BIB21919-bib-0131|da21919-cit-0131","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1007\/s00702-002-0774-8","article-title":"Plasma gamma-amino-butyric acid (GABA) levels in cholecystokinine-tetrapeptide (CCK-4) induced anxiety","volume":"110","author":"Zwanzger","year":"2003","journal-title":"J Neural Transm"},{"key":"10.1002\/da.21919-BIB21919-bib-0132|da21919-cit-0132","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/0006-8993(87)90784-0","article-title":"Release of cholecystokinin from rat cerebral cortex in vivo: role of GABAand glutamate receptor systems","volume":"406","author":"Yaksh","year":"1987","journal-title":"Brain Res"},{"key":"10.1002\/da.21919-BIB21919-bib-0133|da21919-cit-0133","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/0014-2999(90)90594-V","article-title":"Long-term diazepam treatment produces changes in cholecystokinin receptor binding in rat brain","volume":"180","author":"Harro","year":"1990","journal-title":"Eur J Pharmacol"},{"key":"10.1002\/da.21919-BIB21919-bib-0134|da21919-cit-0134","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1007\/BF02244646","article-title":"The benzodiazepine antagonist flumazenil blocks the effects of CCKreceptor agonists and antagonists in the elevated plus-maze","volume":"110","author":"Chopin","year":"1993","journal-title":"Psychopharmacology"},{"key":"10.1002\/da.21919-BIB21919-bib-0135|da21919-cit-0135","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/0143-4179(83)90033-1","article-title":"Facilitation of GABArelease by cholecystokinin and caerulein in rat cerebral cortex","volume":"3","author":"Sheehan","year":"1983","journal-title":"Neuropeptides"},{"key":"10.1002\/da.21919-BIB21919-bib-0136|da21919-cit-0136","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/0014-2999(93)90029-H","article-title":"Cholecystokinin-8 increases K(+)-evoked [3H] gamma-aminobutyric acid release in slices from various brain areas","volume":"250","author":"Perez de la Mora","year":"1993","journal-title":"Eur J Pharmacol"},{"key":"10.1002\/da.21919-BIB21919-bib-0137|da21919-cit-0137","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/0143-4179(95)90034-9","article-title":"Cholecystokinin-GABAinteractions in rat striatum","volume":"29","author":"Rakovska","year":"1995","journal-title":"Neuropeptides"},{"key":"10.1002\/da.21919-BIB21919-bib-0138|da21919-cit-0138","doi-asserted-by":"crossref","first-page":"1973","DOI":"10.1046\/j.1471-4159.1999.01973.x","article-title":"Effects of cholecystokinin peptides and GV150013, a selective cholecystokininB receptor antagonist, on electrically evoked endogenous GABArelease from rat cortical slices","volume":"73","author":"Ferraro","year":"1999","journal-title":"J Neurochem"},{"key":"10.1002\/da.21919-BIB21919-bib-0139|da21919-cit-0139","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/0304-3940(95)11711-5","article-title":"Effect of local cholecystokinin-8 administration on extracellular levels of amino acids and glycolytic products monitored by in vivo microdialysis in the fronto-parietal cortex of the rat","volume":"194","author":"Godukhin","year":"1995","journal-title":"Neurosci Lett"},{"key":"10.1002\/da.21919-BIB21919-bib-0140|da21919-cit-0140","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1007\/PL00004986","article-title":"Cholecystokinin-8S increases dynorphin B, aspartate and glutamate release in the fronto-parietal cortex of the rat via different receptor subtypes","volume":"355","author":"You","year":"1997","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"10.1002\/da.21919-BIB21919-bib-0141|da21919-cit-0141","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/S0197-0186(02)00052-9","article-title":"Effects of cholecystokinin tetrapeptide (CCK(4)) and of anxiolytic drugs on GABAoutflow from the cerebral cortex of freely moving rats","volume":"42","author":"Siniscalchi","year":"2003","journal-title":"Neurochem Int"},{"issue":"Suppl 2","key":"10.1002\/da.21919-BIB21919-bib-0142|da21919-cit-0142","first-page":"4","article-title":"Toward an integrated neurobiology of panic disorder","volume":"58","author":"Goddard","year":"1997","journal-title":"J Clin Psychiat"},{"key":"10.1002\/da.21919-BIB21919-bib-0143|da21919-cit-0143","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/S0924-977X(98)00020-0","article-title":"CCK4-induced panic in healthy subjects I: psychological and cardiovascular effects","volume":"9","author":"Jerabek","year":"1999","journal-title":"Eur Neuropsychopharmacol"},{"key":"10.1002\/da.21919-BIB21919-bib-0144|da21919-cit-0144","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/S0006-3223(97)00536-2","article-title":"The role of the beta-noradrenergic system in cholecystokinin-tetrapeptide-induced panic symptoms","volume":"44","author":"Le Melledo","year":"1998","journal-title":"Biol Psychiat"},{"key":"10.1002\/da.21919-BIB21919-bib-0145|da21919-cit-0145","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1016\/j.jpsychires.2010.04.004","article-title":"CCK-4: Psychophysiological conditioning elicits features of spontaneous panic attacks","volume":"44","author":"Hinkelmann","year":"2010","journal-title":"J Psychiat Res"},{"key":"10.1002\/da.21919-BIB21919-bib-0146|da21919-cit-0146","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/S0893-133X(98)00124-9","article-title":"Dose response of adrenocorticotropin and cortisol to the CCK-B agonist pentagastrin","volume":"21","author":"Abelson","year":"1999","journal-title":"Neuropsychopharmacology"},{"key":"10.1002\/da.21919-BIB21919-bib-0147|da21919-cit-0147","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1176\/ajp.153.1.114","article-title":"Elevated plasma levels of neuropeptide Yin patients with panic disorder","volume":"153","author":"Boulenger","year":"1996","journal-title":"Am J Psychiat"},{"key":"10.1002\/da.21919-BIB21919-bib-0148|da21919-cit-0148","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/S0006-8993(03)03087-7","article-title":"Expression of neuropeptide Y and cholecystokinin in the rat brain by chronic mild stress","volume":"983","author":"Kim","year":"2003","journal-title":"Brain Res"},{"key":"10.1002\/da.21919-BIB21919-bib-0149|da21919-cit-0149","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1053\/j.gastro.2009.08.051","article-title":"Neuropeptide S receptor induces neuropeptide expression and associates with intermediate phenotypes of functional gastrointestinal disorders","volume":"138","author":"Camilleri","year":"2010","journal-title":"Gastroenterology"},{"key":"10.1002\/da.21919-BIB21919-bib-0150|da21919-cit-0150","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1016\/j.neuropharm.2004.02.006","article-title":"Melatonin MT(1\/2) receptor stimulation reduces cortical overflow of cholecystokinin-like material in a model of anticipation of social defeat in the rat","volume":"46","author":"Becker","year":"2004","journal-title":"Neuropharmacology"},{"key":"10.1002\/da.21919-BIB21919-bib-0151|da21919-cit-0151","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1124\/jpet.109.150649","article-title":"Cannabinoid CB1 and cholecystokinin CCK2 receptors modulate, in an opposing way, electrically evoked [3H]GABAefflux from rat cerebral cortex cell cultures: possible relevance for cortical GABAtransmission and anxiety","volume":"329","author":"Antonelli","year":"2009","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1002\/da.21919-BIB21919-bib-0152|da21919-cit-0152","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1038\/npp.2008.97","article-title":"Functional interactions between endocannabinoid and CCKneurotransmitter systems may be critical for extinction learning","volume":"34","author":"Chhatwal","year":"2009","journal-title":"Neuropsychopharmacology"},{"key":"10.1002\/da.21919-BIB21919-bib-0153|da21919-cit-0153","doi-asserted-by":"crossref","first-page":"3508","DOI":"10.2174\/138161208786848784","article-title":"GABAergic and endocannabinoid dysfunction in anxiety - future therapeutic targets?","volume":"14","author":"Domschke","year":"2008","journal-title":"Curr Pharm Des"},{"key":"10.1002\/da.21919-BIB21919-bib-0154|da21919-cit-0154","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1586\/ern.10.76","article-title":"Genetics of panic disorder: focus on association studies and therapeutic perspectives","volume":"10","author":"Jacob","year":"2010","journal-title":"Expert Rev Neurother"},{"key":"10.1002\/da.21919-BIB21919-bib-0155|da21919-cit-0155","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/S0006-3223(01)01322-1","article-title":"Evidence for a susceptibility locus for panic disorder near the catechol-O-methyltransferase gene on chromosome 22","volume":"51","author":"Hamilton","year":"2002","journal-title":"Biol Psychiat"},{"key":"10.1002\/da.21919-BIB21919-bib-0156|da21919-cit-0156","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1002\/ajmg.b.30494","article-title":"Meta-analysis of COMTval158met in panic disorder: ethnic heterogeneity and gender specificity","volume":"144B","author":"Domschke","year":"2007","journal-title":"Am J Med Genet B Neuropsychiat Genet"},{"key":"10.1002\/da.21919-BIB21919-bib-0157|da21919-cit-0157","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1093\/hmg\/8.4.621","article-title":"Excess of high activity monoamine oxidase Agene promoter alleles in female patients with panic disorder","volume":"8","author":"Deckert","year":"1999","journal-title":"Hum Mol Genet"},{"key":"10.1002\/da.21919-BIB21919-bib-0158|da21919-cit-0158","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.psychres.2004.05.012","article-title":"Association studies of MAO-A, COMT, and 5-HTTgenes polymorphisms in patients with anxiety disorders of the phobic spectrum","volume":"128","author":"Samochowiec","year":"2004","journal-title":"Psychiat Res"},{"key":"10.1002\/da.21919-BIB21919-bib-0159|da21919-cit-0159","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1097\/00041444-200503000-00004","article-title":"Association study of 90 candidate gene polymorphisms in panic disorder","volume":"15","author":"Maron","year":"2005","journal-title":"Psychiat Genet"},{"key":"10.1002\/da.21919-BIB21919-bib-0160|da21919-cit-0160","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1038\/sj.mp.4000345","article-title":"Systematic mutation screening and association study of the A1 and A2a adenosine receptor genes in panic disorder suggest a contribution of the A2a gene to the development of disease","volume":"3","author":"Deckert","year":"1998","journal-title":"Mol Psychiat"},{"key":"10.1002\/da.21919-BIB21919-bib-0161|da21919-cit-0161","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1038\/mp.2010.81","article-title":"Neuropeptide Sreceptor gene - converging evidence for a role in panic disorder","volume":"16","author":"Domschke","year":"2011","journal-title":"Mol Psychiat"},{"key":"10.1002\/da.21919-BIB21919-bib-0162|da21919-cit-0162","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1038\/sj.mp.4000705","article-title":"Function of the C-36 to T polymorphism in the human cholecystokinin gene promoter","volume":"5","author":"Hansen","year":"2000","journal-title":"Mol Psychiat"},{"key":"10.1002\/da.21919-BIB21919-bib-0163|da21919-cit-0163","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1002\/(SICI)1096-8628(19980508)81:3<228::AID-AJMG5>3.0.CO;2-S","article-title":"Possible association of a cholecystokinin promotor polymorphism (CCK-36CT) with panic disorder","volume":"81","author":"Wang","year":"1998","journal-title":"Am J Med Genet"},{"key":"10.1002\/da.21919-BIB21919-bib-0164|da21919-cit-0164","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/S0165-1781(98)00063-8","article-title":"An association of NAGlevels and a mutation of the CCKgene in panic disorder patients","volume":"80","author":"Garvey","year":"1998","journal-title":"Psychiat Res"},{"key":"10.1002\/da.21919-BIB21919-bib-0165|da21919-cit-0165","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1097\/YPG.0b013e32833511a8","article-title":"Gene variations in the cholecystokinin system in patients with panic disorder","volume":"20","author":"Koefoed","year":"2010","journal-title":"Psychiat Genet"},{"key":"10.1002\/da.21919-BIB21919-bib-0166|da21919-cit-0166","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1038\/sj.mp.4000507","article-title":"Investigation of cholecystokinin system genes in panic disorder","volume":"4","author":"Kennedy","year":"1999","journal-title":"Mol Psychiat"},{"key":"10.1002\/da.21919-BIB21919-bib-0167|da21919-cit-0167","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1038\/sj.mp.4000788","article-title":"No association or linkage between polymorphisms in the genes encoding cholecystokinin and the cholecystokinin B receptor and panic disorder","volume":"6","author":"Hamilton","year":"2001","journal-title":"Mol Psychiat"},{"key":"10.1002\/da.21919-BIB21919-bib-0168|da21919-cit-0168","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1002\/ajmg.10043","article-title":"Association studies of the CTrepeat polymorphism in the 5\u2032 upstream region of the cholecystokinin Breceptor gene with panic disorder and schizophrenia in Japanese subjects","volume":"105","author":"Hattori","year":"2001","journal-title":"Am J Med Genet"},{"key":"10.1002\/da.21919-BIB21919-bib-0169|da21919-cit-0169","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1007\/978-3-7091-0579-5_17","article-title":"Cholecystokinin- and cholecystokinin-B-receptor gene polymorphisms in panic disorder","volume":"68","author":"Hosing","year":"2004","journal-title":"J Neural Transm Suppl"},{"key":"10.1002\/da.21919-BIB21919-bib-0170|da21919-cit-0170","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1038\/sj.mp.4000875","article-title":"Identification of a compound short tandem repeat stretch in the 5'-upstream region of the cholecystokinin gene, and its association with panic disorder but not with schizophrenia","volume":"6","author":"Hattori","year":"2001","journal-title":"Mol Psychiat"},{"key":"10.1002\/da.21919-BIB21919-bib-0171|da21919-cit-0171","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1002\/ajmg.b.10058","article-title":"Transcriptional activities of cholecystokinin promoter haplotypes and their relevance to panic disorder susceptibility","volume":"118B","author":"Ebihara","year":"2003","journal-title":"Am J Med Genet B Neuropsychiat Genet"},{"key":"10.1002\/da.21919-BIB21919-bib-0172|da21919-cit-0172","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1002\/ajmg.b.10020","article-title":"Association between the CCK-Areceptor gene and panic disorder","volume":"118B","author":"Ise","year":"2003","journal-title":"Am J Med Genet B Neuropsychiat Genet"},{"key":"10.1002\/da.21919-BIB21919-bib-0173|da21919-cit-0173","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1002\/ajmg.b.20160","article-title":"Association of cholecystokinin-A receptor gene polymorphisms and panic disorder in Japanese","volume":"127B","author":"Miyasaka","year":"2004","journal-title":"Am J Med Genet B Neuropsychiat Genet"},{"key":"10.1002\/da.21919-BIB21919-bib-0174|da21919-cit-0174","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1002\/ajmg.1496","article-title":"Linkage genome scan for loci predisposing to panic disorder or agoraphobia","volume":"105","author":"Gelernter","year":"2001","journal-title":"Am J Med Genet"},{"key":"10.1002\/da.21919-BIB21919-bib-0175|da21919-cit-0175","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1002\/(SICI)1096-8628(19960726)67:4<401::AID-AJMG14>3.0.CO;2-N","article-title":"Missense mutation of the cholecystokinin B receptor gene: lack of association with panic disorder","volume":"67","author":"Kato","year":"1996","journal-title":"Am J Med Genet"},{"key":"10.1002\/da.21919-BIB21919-bib-0176|da21919-cit-0176","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1007\/s007020170033","article-title":"Association studies of the cholecystokinin Breceptor and A2a adenosine receptor genes in panic disorder","volume":"108","author":"Yamada","year":"2001","journal-title":"J Neural Transm"},{"key":"10.1002\/da.21919-BIB21919-bib-0177|da21919-cit-0177","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1002\/ajmg.b.30902","article-title":"Identification of new putative susceptibility genes for several psychiatric disorders by association analysis of regulatory and non-synonymous SNPs of 306 genes involved in neurotransmission and neurodevelopment","volume":"150B","author":"Gratacos","year":"2009","journal-title":"Am J Med Genet B Neuropsychiat Genet"},{"key":"10.1002\/da.21919-BIB21919-bib-0178|da21919-cit-0178","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1002\/ajmg.b.30898","article-title":"Peripheral gene expression profiling of CCK-4-induced panic in healthy subjects","volume":"153B","author":"Maron","year":"2010","journal-title":"Am J Med Genet B Neuropsychiat Genet"},{"key":"10.1002\/da.21919-BIB21919-bib-0179|da21919-cit-0179","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1080\/713783681","article-title":"Cholecystokinin and panic disorder: past and future clinical research strategies","volume":"234","author":"Bradwejn","year":"2001","journal-title":"Scand J Clin Lab Invest Suppl"}],"container-title":["Depression and Anxiety"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fda.21919","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1002\/da.21919\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,24]],"date-time":"2024-04-24T03:11:59Z","timestamp":1713928319000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/da.21919"}},"subtitle":["The Role of CCK in Panic Disorder"],"short-title":[],"issued":{"date-parts":[[2012,5,2]]},"references-count":179,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2012,9]]}},"URL":"https:\/\/doi.org\/10.1002\/da.21919","relation":{},"ISSN":["1091-4269"],"issn-type":[{"value":"1091-4269","type":"print"}],"subject":[],"published":{"date-parts":[[2012,5,2]]}}}